Gene · 51752
Papers1,796
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,796
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Controlling intracellular processing to enhance spherical nucleic acid immune stimulation. | Proc Natl Acad Sci U S A | 2025 | 41183209 | PubTator, text mining | PubMed |
| Engineering Universal Cancer Immunity: Non-Tumor-Specific mRNA Vaccines Trigger Epitope Spreading in Cold Tumors. | Vaccines (Basel) | 2025 | 41012173 | PubTator, text mining | PubMed |
| Genes and environment profoundly affect the human virome. | bioRxiv | 2025 | 40964300 | PubTator, text mining | PubMed |
| Evaluating the causal effect of circulating proteome on the risk of Juvenile idiopathic arthritis: an omics pipeline study. | Pediatr Rheumatol Online J | 2025 | 40898345 | PubTator, text mining | PubMed |
| Predictive value of MHC-related genes in cervical cancer: implications for immunotherapy and prognostic nomogram development. | Discov Oncol | 2025 | 40888998 | PubTator, text mining | PubMed |
| Bibliometric analysis of research on cervical cancer and miRNAs from 2010 to 2024: research trends, hotspots, and prospects. | Discov Oncol | 2025 | 40864203 | PubTator, text mining | PubMed |
| Tailoring Inflammatory Biomarker Assessment in Axial Spondyloarthritis: A Comparative Study of Erythrocyte Sedimentation Rate and C-Reactive Protein Across Disease Profiles. | J Pers Med | 2025 | 40863391 | PubTator, text mining | PubMed |
| Tamarixetin Suppresses Colorectal Cancer Progression by Targeting DPP7-Mediated WNT3A/β-Catenin Signalling Pathway. | J Cell Mol Med | 2025 | 40845164 | PubTator, text mining | PubMed |
| Inhibition of ATM enhances the immunogenicity of triple-negative breast cancer by promoting MHC-I expression. | Cell Death Dis | 2025 | 40825766 | PubTator, text mining | PubMed |
| Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. | Signal Transduct Target Ther | 2025 | 40739089 | PubTator, text mining | PubMed |
| Network pharmacology and molecular docking reveal that honeysuckle blood components mitigate smoke inhalation-induced lung injury via NF-κB pathway. | Allergol Immunopathol (Madr) | 2025 | 40682227 | PubTator, text mining | PubMed |
| Corilagin regulates antigen processing and presentation by directly binding to inhibit ERAP1. | Int Immunopharmacol | 2025 | 40680611 | PubTator, text mining | PubMed |
| Utility of serum ERAP1 and ERAP2 as novel biomarkers in the management of recalcitrant warts: A cross-sectional study. | Indian J Dermatol Venereol Leprol | 2025 | 40587547 | PubTator, text mining | PubMed |
| Etiopathogenesis of Behçet's disease: A systematic literature review. | Clin Immunol | 2025 | 40571238 | PubTator, text mining | PubMed |
| Exploring associations of single nucleotide polymorphisms in ERAP1 and ERAP2 with susceptibility to multiple immune-mediated inflammatory diseases. | Hum Immunol | 2025 | 40543396 | PubTator, text mining | PubMed |
| The Genetic Background of Ankylosing Spondylitis Reveals a Distinct Overlap with Autoimmune Diseases: A Systematic Review. | J Clin Med | 2025 | 40507438 | PubTator, text mining | PubMed |
| Discovery of Novel Allosteric Inhibitor Hits for Insulin-Regulated Aminopeptidase Provides Insights on Enzymatic Mechanism. | ACS Omega | 2025 | 40352506 | PubTator, text mining | PubMed |
| Mendelian randomization analysis identifies ERAP1 and IL23R as potential drug targets for ankylosing spondylitis. | Life Sci | 2025 | 40349828 | PubTator, text mining | PubMed |
| Beyond environmental risk: Genetic insights into lung cancer susceptibility through whole exome analysis. | Lung Cancer | 2025 | 40311306 | PubTator, text mining | PubMed |
| Unveiling the impact of ERAP1 and ERAP2 on migration, angiogenesis and ER stress response. | Front Cell Dev Biol | 2025 | 40226591 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51752/papers?page=3